Nanalysis Scientific Corp. (NSCI) Earnings Call Transcripts
Nanalysis Scientific Corp.'s Latest Earnings Call - Q1 FY2026
In Q1 2026, Nanalysis Scientific Corp. reported consolidated revenue of $10.67 million, marking a modest increase of 1% year-over-year. The company experienced a decline in product revenue due to lower bench top sales and the termination of third-party equipment contracts, but this was offset by a rise in Security Services revenue. Adjusted EBITDA improved to $292,000, reflecting operational efficiencies, while the net loss narrowed to $1.28 million. Management did not provide specific guidance for future quarters but expressed optimism about operational improvements and revenue growth potential.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $10.67M (inline) |
| Gross Margin (Product Sales) | 58% (miss) |
| Gross Margin (Security Services) | 19% (positive) |
| Adjusted EBITDA | $292,000 (positive) |
| Net Loss | $1.28M (positive) |
| Term Loan Balance | $3.7M (positive) |
Guidance from management
Management did not provide specific forward guidance but expressed optimism about operational improvements and revenue growth potential in the coming quarters.
What analysts pressed on
Analysts expressed concerns regarding the decline in product revenue and the impact of terminated contracts on future sales. There were also questions about the sustainability of the improved margins in the Security Services segment and the effectiveness of the new leadership in driving growth.
Main topics on the call
- Revenue Composition Changes — Nanalysis reported a consolidated revenue of $10,667,000, which was a slight increase of 1% from the previous year. The decline in product revenue was attributed to 'lower bench top sales and the termination of third-par...
- Gross Margin Variability — The gross margin percentage for product sales decreased to 58% from 66% year-over-year, primarily due to changes in product mix. However, the gross margin for Security Services improved significantly to 19% from 6%, driv...
- Adjusted EBITDA Improvement — Nanalysis reported adjusted EBITDA of $292,000, an increase of $112,000 compared to the same period last year. This improvement was attributed to 'an increase in services margin, lower spending in sales and marketing and...
- Net Loss Reduction — The company recorded a net loss of $1,281,000, which is an improvement of $26,000 from the previous year. Management noted that the decrease in net loss was due to 'improved business margins.'
Read the full Nanalysis Scientific Corp. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Nanalysis Scientific Corp.
Nanalysis Scientific Corp. (NSCI) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on TSXV and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 33 calls on record spanning June 8, 2021 to September 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 33 Nanalysis Scientific Corp. earnings call transcripts on record, spanning June 8, 2021 to September 24, 2026. Based on this history, Nanalysis Scientific Corp. reports quarterly. The most recent call on file is dated September 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- NSCI
- Exchange
- TSXV
- Country
- CA
- Sector
- Health Care
- Calls on record
- 33
- First call
- June 8, 2021
- Most recent
- September 24, 2026
- Reporting cadence
- quarterly